
Georgia Research Alliance
Description
The Georgia Research Alliance (GRA) is a distinctive non-profit organization based in Atlanta, Georgia, dedicated to expanding the research and commercialization capacity within the state's universities. Established in 1990, GRA plays a pivotal role in transforming groundbreaking academic discoveries into viable businesses, thereby fostering economic growth and job creation across Georgia. Its core mission involves recruiting world-class scientists, investing in state-of-the-art research infrastructure, and, critically, providing the necessary capital to launch university-born startups.
Through its GRA Ventures program, the alliance acts as a crucial early-stage investor for companies emerging from Georgia's leading research institutions. GRA Ventures specifically targets startups that are based on university intellectual property and led by experienced entrepreneurs, often serving as the very first institutional investor. The organization typically provides seed funding, with initial investments generally ranging between $150,000 and $500,000. These investments are commonly structured as convertible notes or direct equity, providing essential capital for nascent companies to develop their products, build their teams, and secure further private funding.
GRA's strategic investments have yielded substantial economic impact for the state. Since its inception, the Georgia Research Alliance has been instrumental in helping to launch more than 200 companies, demonstrating a consistent commitment to nurturing innovative ventures. These portfolio companies have collectively attracted over $2.1 billion in private investment, a testament to the quality of the research and the commercial potential identified by GRA. Furthermore, these ventures have contributed significantly to job creation, generating more than 7,900 jobs within Georgia. GRA's unique model effectively bridges the gap between academic research and market commercialization, solidifying Georgia's position as a hub for scientific innovation and entrepreneurial success.
Investor Profile
Georgia Research Alliance has backed more than 154 startups, with 0 new investments in the last 12 months alone. The firm has led 142 rounds, about 92% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, Australia, Sweden.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $150K – $500K.
Stage Focus
- Grant (92%)
- Seed (3%)
- Series A (2%)
- Debt Financing (1%)
- Series E (1%)
- Series B (1%)
- Series C (1%)
Country Focus
- United States (76%)
- Australia (4%)
- Sweden (3%)
- France (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Medical Device
- Pharmaceutical
- Health Diagnostics
- Biopharma
- Life Science
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.